Laura and colleagues showed that inhibition of miR-181a-5p could potentiate oxaliplatin sensitivity of PC cells via suppressing expression of ATM. Moreover, PC patients with better response to FOLFIRINOX displayed lower levels of miR-181a-5p both in cancerous tissues and plasma specimens (Meijer et al., 2020). Here, ATM is linked to pachyonychia congenita.